You are viewing: China Veterinary Contract Manufacturing & Research Market analysis

The China Veterinary Contract Manufacturing & Research Market was valued at $62.7 Million in 2026 and projected to reach to $104.4 Million by 2031, representing a compound annual growth rate of 10.7%. China's veterinary contract manufacturing and research market is positioned for exceptional growth through 2031, driven by rising livestock production, expanding aquaculture industries, and growing pet ownership across urban centers.

China Veterinary Contract Manufacturing & Research Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Veterinary Contract Manufacturing & Research Market Trends and Insights

  • This 10.7% compound annual growth rate significantly outpaces global trends, reflecting China's strategic investments in animal health infrastructure and biotechnology capabilities.
  • China's market growth is driven by increasing demand for veterinary pharmaceuticals, rising pet ownership, and government support for domestic pharmaceutical innovation. The veterinary contract manufacturing sector in China benefits from the country's established pharmaceutical manufacturing base and cost-competitive production capabilities.
  • China's position as a global supplier of active pharmaceutical ingredients and finished veterinary products strengthens its market position.
  • Between 2026 and 2031, China is expected to capture growing market share through expanded research partnerships, regulatory harmonization, and technological advancement in contract research organization services. China's veterinary market dynamics reflect broader trends in livestock modernization and companion animal healthcare expansion.
  • The country's regulatory environment continues to evolve, creating opportunities for contract manufacturers and research organizations to support both domestic and international clients seeking manufacturing and development services..

Key Market Statistics

  • CAGR (2026-2031) 10.7% CAGR
  • Market Size, 2026 ~USD 62.7 Million
  • Forecast, 2031 ~USD 104.4 Million
  • Country China

China Veterinary Contract Manufacturing & Research Market Overview

Rapid Market Expansion :

China's veterinary contract manufacturing and research market is growing at 10.7% CAGR, significantly outpacing the global rate of 7.7%, driven by increased domestic demand for animal health solutions and biotechnology advancement.

Strategic Government Support :

China's government investments in animal health infrastructure and biotechnology capabilities are accelerating market growth, positioning the country as a key hub for veterinary contract manufacturing and research services in Asia.

Substantial Market Valuation :

The market is valued at $62.7 million in 2026 and projected to reach $104.4 million by 2031, representing a 66.5% increase over five years and reflecting strong investor confidence in China's veterinary sector.

Growing Pharmaceutical Integration :

Increasing collaboration between Chinese pharmaceutical companies and veterinary contract manufacturers is expanding service offerings, including drug development, clinical trials, and manufacturing capabilities for animal health products.

China Veterinary Contract Manufacturing & Research Market Dynamics

  • The country's competitive manufacturing costs, improving regulatory frameworks, and technological advancements in biotechnology are attracting both domestic and international pharmaceutical companies seeking contract manufacturing partnerships. Government initiatives promoting animal health and food safety standards are creating additional demand for specialized research and manufacturing services.
  • As China strengthens its position in the global veterinary supply chain, the market will benefit from increased outsourcing from multinational pharmaceutical firms and the development of innovative veterinary therapeutics tailored to Asian livestock and companion animal markets..

Related Ecosystem

Animal Health

Top Technologies
    Top Companies

      Key Takeaways

      • China's veterinary contract manufacturing market is valued at $62.7 million in 2026, growing at 10.7% CAGR through 2031.
      • China's market is projected to reach $104.4 million by 2031, driven by rising pet ownership and livestock modernization.
      • China's cost-competitive manufacturing and established pharmaceutical infrastructure position it as a key global supplier.
      • China's regulatory evolution and government support are creating expanded opportunities for contract research and manufacturing services.

      Veterinary Contract Manufacturing & Research Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment CDMO SERVICES (Service)
      Forecast Period 2026–2031
      Growth Rate CAGR of 7.7% from 2026 to 2031
      Largest Segment CDMO SERVICES (Service)
      Market Size Base Year (Billions) ~USD 6.38 (2026)
      Revenue Forecast (Billions) ~USD 9.24 (2031)
      Segments Covered Service, Type

      China Veterinary Contract Manufacturing & Research Market Report Segmentation

      2 segment dimensions are covered across the global market.

      By Service

      • Cdmo Services
      • Cro Services

      By Type

      • Analytical & Bioanalytical Services And Quality Assurance
      • Discovery & Pre-Clinical Studies
      • Manufacturing
      • Packaging & Labeling
      • Process Api & Formulation Development
      • Quality/Stability & Post-Market Support
      • Regulatory Affairs & Consulting
      • Veterinary Clinical Trials

      CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031

      Segment20242025202620272028202920302031CAGR (%)
      MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS2022.224.727.430.533.937.641.811.1
      MULTINATIONAL ANIMAL HEALTH COMPANIES23.225.327.630.132.835.83942.69.1
      START-UPS & VETERINARY BIOTECH FIRMS8.19.210.511.913.615.417.62013.8
      TOTAL51.356.762.769.476.88594.2104.410.7

      Target Audience

      • Pharmaceutical & Biotech Companies : Multinational and domestic pharmaceutical firms seeking contract manufacturing and research partnerships in China need this data to evaluate market opportunities, identify capable partners, and plan outsourcing strategies.
      • Contract Research Organizations (CROs) : Veterinary CROs and contract manufacturers require detailed market intelligence to assess China's growth potential, benchmark competitive positioning, and develop expansion strategies in this high-growth market.
      • Investment & Private Equity Firms : Investors evaluating opportunities in China's animal health sector need comprehensive market sizing, growth forecasts, and trend analysis to make informed investment decisions and identify acquisition targets.
      • Animal Health Distributors & Suppliers : Distributors and suppliers of veterinary products and services require market data to understand demand drivers, identify growth segments, and optimize supply chain strategies for the Chinese market.
      • Government & Regulatory Bodies : Chinese regulatory agencies and government bodies benefit from market intelligence to inform policy development, infrastructure investments, and strategic initiatives supporting the veterinary healthcare sector's growth.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise valuation data for China's veterinary contract manufacturing market ($62.7M in 2026) with verified 10.7% CAGR projections through 2031, enabling accurate business planning and investment decisions.
      • Competitive Positioning Intelligence : Understand China's market dynamics relative to global trends (7.7% CAGR), identifying competitive advantages and opportunities for market entry, expansion, or partnership development in Asia's fastest-growing veterinary sector.
      • Strategic Investment Guidance : Access comprehensive market outlook analysis highlighting government support, infrastructure investments, and regulatory trends specific to China, supporting capital allocation and long-term strategic planning decisions.
      • Customer & Partner Identification : Leverage detailed market segmentation and audience insights to identify high-potential pharmaceutical companies, contract manufacturers, and research institutions actively operating in China's veterinary market.
      • Risk Mitigation & Forecasting : Utilize five-year forecast data and market trend analysis to anticipate regulatory changes, competitive pressures, and emerging opportunities, reducing business risks and improving strategic foresight in China's dynamic market.

      Frequently asked questions

      What is the current size of China's veterinary contract manufacturing market?

      China's veterinary contract manufacturing and research market is valued at $62.7 million in 2026.

      What is the projected market size for China by 2031?

      China's market is projected to reach $104.4 million by 2031, representing a 10.7% CAGR from 2026.

      What factors are driving growth in China's veterinary contract manufacturing sector?

      Growth in China is driven by increasing pet ownership, livestock modernization, government pharmaceutical innovation support, and expanding international partnerships.

      How does China's growth rate compare to global trends?

      China's 10.7% CAGR significantly exceeds the global average of 7.7%, reflecting stronger market dynamics and investment in veterinary healthcare.

      What competitive advantages does China offer in veterinary contract manufacturing?

      China offers cost-competitive production, established pharmaceutical manufacturing infrastructure, and a strong position as a global supplier of active pharmaceutical ingredients and finished products.

      RESEARCH METHODOLOGY

      This research study extensively utilized both primary and secondary sources. It involved analyzing various factors that influence the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and the strategies employed by key players.

      Secondary Research

      This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary contract manufacturing & research market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments about both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

      Primary Research

      In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development, and operations managers, as well as presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary contract manufacturing & research market. Primary sources from the demand side include R&D scientists and researchers in animal health companies, veterinary clinicians, and veterinary biotech firms developing veterinary therapeutics and technologies.

      Veterinary Contract Manufacturing and Research Market 
 Size, and Share

      Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
      Note 2: Other designations include sales, marketing, and product/service managers.

      Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The total size of the veterinary contract manufacturing & research market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

      Veterinary Contract Manufacturing and Research Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the veterinary contract manufacturing & research market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and obtain precise statistics for all segments and subsegments.

      Market Definition

      The veterinary contract research organization (CRO) market comprises third-party service providers that support animal-health companies in the outsourced research and development of veterinary pharmaceuticals, biologics, vaccines, and related products. Veterinary CROs provide services across the product lifecycle, including discovery support, preclinical studies, target animal safety, clinical field trials, bioequivalence studies, regulatory consulting, and post-approval research, in compliance with veterinary regulatory standards. These services are primarily used by animal-health pharmaceutical companies, biotechnology firms, and vaccine developers to reduce development timelines, access specialized expertise, manage regulatory complexity, and optimize R&D costs without maintaining a complete in-house research infrastructure. The veterinary contract development and manufacturing organization (CDMO) market consists of third-party manufacturers that provide outsourced development, scale-up, and commercial manufacturing services for veterinary drugs, biologics, vaccines, and related products. Veterinary CDMOs support animal-health companies through process and formulation development, API and finished dosage form manufacturing, fill-finish operations, packaging and labeling, quality control, stability testing, and regulatory manufacturing support, operating in accordance with veterinary GMP and biologics regulations.

      These services enable animal-health companies to outsource capital-intensive manufacturing activities, increase production flexibility, manage capacity constraints, and accelerate market entry, particularly for complex formulations, sterile injectables, and veterinary vaccines.

      Key Stakeholders

      • Animal-health pharmaceutical companies
      • Veterinary biotechnology companies
      • Veterinary biologics & vaccine developers
      • Veterinary contract development & manufacturing organizations (CDMOs)
      • Veterinary contract research organizations (CROs)
      • Preclinical & toxicology research laboratories (GLP & non-GLP)
      • Clinical trial management organizations for veterinary studies
      • Regulatory consulting firms specializing in VICH / EMA / FDA-CVM
      • Quality control & analytical testing laboratories (veterinary-focused)
      • Veterinary formulation & process development service providers
      • Packaging, filling, and labeling service providers for veterinary products
      • Animal research facilities & field trial centers
      • Veterinary academic research institutes
      • Livestock research institutions & herd-health trial networks
      • Raw material suppliers for veterinary APIs, excipients, and biologics components

      Report Objectives

      • To define, describe, segment, and forecast the veterinary contract manufacturing & research market by service, product type, animal type, end user, and region
      • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall veterinary contract manufacturing & research market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the veterinary contract manufacturing & research market in five central regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players in the veterinary contract manufacturing & research market and comprehensively analyze their core competencies and market shares
      • To track and analyze competitive developments such as acquisitions, service launches, expansions, collaborations, agreements, and partnerships

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

      Company Information
      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe veterinary contract manufacturing & research market into Austria, Finland, Switzerland, and other countries
      • Further breakdown of the Rest of Latin American veterinary contract manufacturing & research market into Colombia, Chile, and other countries
      Competitive Landscape Assessment
      • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary contract manufacturing & research market
      • Competitive leadership mapping for established players in the US

       

      Get the Full Veterinary Contract Manufacturing & Research Market Report

      Full forecast, segment splits, and company analysis for all Veterinary Contract Manufacturing & Research Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status